Innovation
5 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 167 times.
| Year | Filings |
|---|---|
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
Social engagement
Social engagement: 7K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; lead investors include Gimv, Pfizer, Mission BioCapital, BioMedPartners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 53% |
| Private equity | 1 | 6% |
| Angel & family office | 1 | 6% |
| Other / undisclosed | 6 | 35% |
Recent activity
5 Jan 2026
Leadership hire
Chief Executive Officer
5 Jan 2026
Leadership hire
CEO